CD81 promotes OC progression by enhancing Bnip3-dependent mitophagy in Tim4+ TAMs via the FAK/PCS/Cdh1 pathway. Stable CD81 knock-down ameliorated disease progression and reversed tumor immunity alterations. Here, PTK2 is linked to neoplasm.